Wimbledon: Zverev uses insulin in the final against Sinner and demystifies diabetes in tennis

German tennis player Alexander Zverev drew attention at Wimbledon on July 12, 2026, when he administered insulin on court during the final match against Jannik Sinner. The athlete has lived with type 1 diabetes since he was four years old, and the action highlighted the management of the condition in a high-performance scenario.
Currently 29 years old, Zverev uses an advanced continuous glucose monitoring system. This device is crucial so that he can monitor his levels in real time and make the necessary adjustments to his medication during competitions.
Permission to use these control devices and administer insulin is granted to Zverev during all official competitions, following the intervals defined by the tournament rules. This practice is essential to preserve glucose balance in high-intensity matches, especially those that last for long sets.
Zverev himself emphasizes that diabetes has never been an obstacle to his development in professional tennis. However, he emphasizes the need for rigorous planning and ongoing care to manage the condition.
Diagnosed with the condition at the age of four, the tennis player kept his situation private for many years. He later chose to make his experience public with the aim of raising awareness about diabetes, especially among young athletes.
In 2022, Alexander Zverev established the Alexander Zverev Foundation, an initiative dedicated to providing support to children living with diabetes and promoting research into the disease.






